Kumba Iron Ore Limited (KIROY)

CTI BioPharma Balance Sheet

Financials in millions ZAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,347	16,913	17,722	16,424	17,925	22,707
Cash & Short-Term Investments	16,347	16,913	17,722	16,424	17,925	22,707
Cash Growth	3.15%	-4.57%	7.90%	-8.37%	-21.06%	76.50%
Accounts Receivable	5,371	2,473	6,351	2,519	4,707	6,752
Other Receivables	89	3,331	3,517	2,909	3,088	1,808
Receivables	5,460	5,804	9,868	5,428	7,795	8,560
Inventory	9,509	9,605	11,398	8,529	6,781	5,858
Prepaid Expenses	-	106	122	127	99	81
Other Current Assets	-	431	391	364	265	115
Total Current Assets	31,316	32,859	39,501	30,872	32,865	37,321
Property, Plant & Equipment	56,959	3,344	9	43,296	43,626	40,630
Long-Term Investments	22	23	24	50	50	-
Long-Term Deferred Tax Assets	-	-	-	1	1	1
Other Long-Term Assets	9,847	62,520	59,190	8,440	5,341	4,565
Total Assets	98,144	98,746	98,724	82,659	81,883	82,517
Accounts Payable	9,397	6,960	6,513	6,077	7,234	4,629
Accrued Expenses	-	1,407	2,222	1,553	811	903
Short-Term Debt	-	2,003	4,144	6,791	-	-
Current Portion of Leases	117	123	176	147	146	179
Current Income Taxes Payable	161	24	229	169	262	616
Current Unearned Revenue	344	449	553	199	389	194
Other Current Liabilities	276	1,114	922	520	1,187	1,278
Total Current Liabilities	10,295	12,080	14,759	15,456	10,029	7,799
Long-Term Leases	121	70	179	157	275	335
Long-Term Deferred Tax Liabilities	14,720	14,106	11,860	10,529	10,526	9,586
Other Long-Term Liabilities	3,100	3,190	3,704	2,700	2,595	2,607
Total Liabilities	28,236	29,446	30,502	28,842	23,425	20,327
Common Stock	3	3	3	3	3	3
Additional Paid-In Capital	364	364	364	364	364	364
Retained Earnings	50,269	49,566	48,772	38,609	42,695	46,121
Treasury Stock	-582	-557	-599	-618	-557	-485
Comprehensive Income & Other	3,210	3,439	3,479	2,688	2,112	1,443
Total Common Equity	53,264	52,815	52,019	41,046	44,617	47,446
Minority Interest	16,644	16,485	16,203	12,771	13,841	14,744
Shareholders' Equity	69,908	69,300	68,222	53,817	58,458	62,190
Total Liabilities & Equity	98,144	98,746	98,724	82,659	81,883	82,517
Total Debt	238	2,196	4,499	7,095	421	514
Net Cash (Debt)	16,109	14,717	13,223	9,329	17,504	22,193
Net Cash Growth	10.42%	11.30%	41.74%	-46.70%	-21.13%	80.09%
Net Cash Per Share	50.09	45.75	41.10	29.00	54.39	68.97
Filing Date Shares Outstanding	320.73	320.87	320.95	320.92	320.88	320.6
Total Common Shares Outstanding	320.73	320.87	320.95	320.92	320.88	320.6
Working Capital	21,021	20,779	24,742	15,416	22,836	29,522
Book Value Per Share	166.07	164.60	162.08	127.90	139.04	147.99
Tangible Book Value	53,264	52,815	52,019	41,046	44,617	47,446
Tangible Book Value Per Share	166.07	164.60	162.08	127.90	139.04	147.99
Land	-	338	344	350	350	350
Buildings	-	12,928	10,211	10,013	10,679	10,474
Machinery	-	-	-1,856	41,757	41,642	40,608
Construction In Progress	-	10,740	13,872	10,725	7,059	2,508

Source: S&P Global Market Intelligence. Standard template. Financial Sources.